Log in
Login
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nyse  >  Bristol-Myers Squibb Co    BMY

Delayed Quote. Delayed  - 07/01 04:56:02 pm
74.01 USD   +0.63%
01:09p BRISTOL MYERS S : BMS and PsiOxus to evaluate Opdivo and enadenotuci..
06/30 IMPERIAL INNOVA : Says PsiOxus Signs Deal With Bristol-Myers Squibb
06/30 BRISTOL MYERS S : and PsiOxus Therapeutics Announce Immuno-Oncology ..
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nyse
06/27/2016 06/28/2016 06/29/2016 06/30/2016 07/01/2016 Date
70.32(c) 72.01(c) 73(c) 73.55(c) 74.01 Last
7 477 388 7 066 389 6 539 785 5 763 885 768 620 Volume
-0.41% +2.40% +1.37% +0.75% +0.63% Change
More quotes
Financials ($)
Sales 2016 18 491 M
EBIT 2016 4 807 M
Net income 2016 4 066 M
Debt 2016 802 M
Yield 2016 2,10%
Sales 2017 20 781 M
EBIT 2017 6 263 M
Net income 2017 5 139 M
Finance 2017 1 144 M
Yield 2017 2,24%
P/E ratio 2016 29,75
P/E ratio 2017 24,02
EV / Sales2016 6,68x
EV / Sales2017 5,85x
Capitalization 122 778 M
More Financials
Company
Bristol-Myers Squibb Co. engages in the discovery, development, licensing, manufacturing, marketing, distribution, and sale of biopharmaceutical products.Its pharmaceutical products include chemically-synthesized drugs or small molecules and an increasing portion of products produced from... 
Sector
Pharmaceuticals
Calendar
07/28Earnings Release
More about the company
Surperformance© ratings of Bristol-Myers Squibb Co
Trading Rating : Investor Rating :
More Ratings
Latest news on BRISTOL-MYERS SQUIBB CO
01:09p BRISTOL MYERS SQUIBB : BMS and PsiOxus to evaluate Opdivo and enadenotucirev in ..
10:49a BRISTOL MYERS SQUIBB : Study Data from Bristol-Myers Squibb Update Knowledge of ..
06/30 BRISTOL MYERS SQUIBB : Trademark Application for "ENFAPORT" Filed
06/30 BRISTOL MYERS SQUIBB : Murdo Gordon Appointed Executive Vice President and Chief..
06/30 BRISTOL MYERS SQUIBB : Recent Studies from Bristol-Myers Squibb Add New Data to ..
06/30 REPORTS FROM BRISTOL-MYERS SQUIBB HI : ...
06/30 IMPERIAL INNOVATIONS : Says PsiOxus Signs Deal With Bristol-Myers Squibb
06/30 BRISTOL MYERS SQUIBB : and PsiOxus Therapeutics Announce Immuno-Oncology Clinica..
06/30 BRISTOL MYERS SQUIBB : and PsiOxus Therapeutics Announce Immuno-Oncology Clinica..
06/29 BRISTOL MYERS SQUIBB : MEDIA STATEMENT Bristol-Myers Squibb’s Response to ..
More news
Sector news : Pharmaceuticals - NEC
01:25pDJAstraZeneca Ends European Licensing Pact With Valeant
12:14pDJAstraZeneca Ends European Pact for New Skin Drug with Valeant -- Update
08:49aDJAstraZeneca Licenses Drugs to LEO Pharma, Ends Valeant License
06/30DJSHIRE : Files 8K - Other Events
06/30DJGLAXOSMITHKLINE : Starts Phase-1 for Antibody Clinical Trial
More sector news : Pharmaceuticals - NEC
News from SeekingAlpha
07:24a Visa Will Bounce Back - Cramer's Lightning Round (6/30/16)
06/30 Bayer Quietly Claims Its Liver Cancer Prize
06/30 Bristol-Myers Squibb and PsiOxus Therapeutics announce clinical collaboration..
06/29 Brexit Analysis - Top 10 U.K. Drugs
06/28 ContraVir Combination Drugs Moving Quickly To Historic Hepatitis B Cure
Advertisement
Chart BRISTOL-MYERS SQUIBB CO
Duration : Period :
Bristol-Myers Squibb Co Technical Analysis Chart | BMY | US1101221083 | 4-Traders
Full-screen chart
Technical analysis trends BRISTOL-MYERS SQU...
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions